Abstract
Background: Some food components influence drug elimination. Previously, we found that caffeic acid, present in coffee, fruits, and vegetables, strongly inhibited human homologs of organic anion transporters (OATs) OAT1 and OAT3, which are responsible for renal tubular secretion of anionic drugs. In this study, we examined the effect of caffeic acid on drug transport by OAT1 and OAT3 in the rat kidney.
Methods: The inhibitory effect of caffeic acid on rat OAT1 and OAT3 was assessed by drug uptake experiment using Xenopus laevis oocytes. Urinary excretion of phenolsulfonphthalein (PSP), a diagnostic agent secreted by renal OATs, was examined in rats, and the influence of caffeic acid was evaluated.
Results: Expression of rat OAT1 (rOAT1) and rOAT3 stimulated uptake of their typical substrates, p-aminohippurate and estrone sulfate, respectively, into oocytes, and caffeic acid inhibited them dose dependently. After intravenous injection of PSP in rats, 42.7% of the dose was excreted into urine up to 60 min, and the simultaneous administration of caffeic acid reduced it to 32.0%.
Conclusions: These findings show that caffeic acid inhibits OAT1 and OAT3 in the rat kidney.
References
1. El-Sheikh AA, Masereeuw R, Russel FG. Mechanisms of renal anionic drug transport. Eur J Pharmacol 2008;585:245–55.10.1016/j.ejphar.2008.02.085Search in Google Scholar
2. Thyss A, Milano G, Kubar J, Namer M, Schneider M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet 1986;327:256–8.10.1016/S0140-6736(86)90786-5Search in Google Scholar
3. Uwai Y, Taniguchi R, Motohashi H, Saito H, Okuda M, Inui K. Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3. Drug Metab Pharmacokinet 2004;19:369–74.10.2133/dmpk.19.369Search in Google Scholar
4. Nozaki Y, Kusuhara H, Kondo T, Iwaki M, Shiroyanagi Y, Nakayama H, et al. Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices. J Pharmacol Exp Ther 2007;322:1162–70.10.1124/jpet.107.121491Search in Google Scholar
5. Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268–9.10.1016/0140-6736(91)90872-MSearch in Google Scholar
6. Harris RZ, Jang GR, Tsunoda S. Dietary effects on drug metabolism and transport. Clin Pharmacokinet 2003;42:1071–88.10.2165/00003088-200342130-00001Search in Google Scholar PubMed
7. Bailey DG. Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol 2010;70:645–55.10.1111/j.1365-2125.2010.03722.xSearch in Google Scholar PubMed PubMed Central
8. Whitley AC, Sweet DH, Walle T. The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metab Dispos 2005;33:1097–100.10.1124/dmd.105.004275Search in Google Scholar PubMed
9. Hong SS, Seo K, Lim SC, Han HK. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3). Pharmacol Res 2007;56:468–73.10.1016/j.phrs.2007.08.007Search in Google Scholar PubMed
10. Uwai Y, Ozeki Y, Isaka T, Honjo H, Iwamoto K. Inhibitory effect of caffeic acid on human organic anion transporters hOAT1 and hOAT3: a novel candidate for food-drug interaction. Drug Metab Pharmacokinet 2011;26:486–93.10.2133/dmpk.DMPK-11-RG-020Search in Google Scholar
11. Wang L, Sweet DH. Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11). Biochem Pharmacol 2012;84:1088–95.10.1016/j.bcp.2012.07.027Search in Google Scholar
12. Clifford MN. Chlorogenic acids and other cinnamates – nature, occurrence and dietary burden. J Sci Food Agric 1999;79: 362–72.10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-DSearch in Google Scholar
13. Sakurai Y, Motohashi H, Ueo H, Masuda S, Saito H, Okuda M, et al. Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res 2004;21:61–7.10.1023/B:PHAM.0000012153.71993.cbSearch in Google Scholar
14. Gaowa A, Motohashi H, Katsura T, Inui K. Effects of metabolic acidosis on expression levels of renal drug transporters. Pharm Res 2011;28:1023–30.10.1007/s11095-010-0348-7Search in Google Scholar
We thank Professor Ken-ichi Inui (Kyoto University Hospital, Kyoto, Japan) for kindly providing pBK-CMV plasmid vectors containing cDNA of rOAT1 and rOAT3.
©2013 by Walter de Gruyter Berlin Boston
